BIO vs MNMD · rev $621.3M vs $1.46B cap
BIO (BIO) versus Mind Medicine Inc (MNMD) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Mind Medicine Inc (MNMD) is a biotechnology company listed on US.
Latest reported BIO revenue for 2017-12-31 was $621.3M. Net income was $82.7M. Revenue was up 24.2% from 2017-03-31 to 2017-12-31. BIO currently screens at market cap $0.
MNMD does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. MNMD currently screens at market cap $1.46B.
Not investment advice. Open the BIO and MNMD stock pages for the full models.
Not investment advice.